These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7408259)

  • 1. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.
    Kitamura H; Nagaki K; Inoshita K; Iida K; Inai S
    Clin Exp Immunol; 1977 Jan; 27(1):34-7. PubMed ID: 849648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
    Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
    Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.
    Grevink ME; Horst G; Limburg PC; Kallenberg CG; Bijl M
    J Autoimmun; 2005 Jun; 24(4):329-36. PubMed ID: 15927794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma levels of complement in patients with acute ischemic stroke.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Petrescu AM; Mitu AC; Iliescu I; Dumitrescu L
    Rom J Intern Med; 2008; 46(1):77-80. PubMed ID: 19157274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.
    Zhang B; Jiang Y; Yang Y; Peng F; Hu X
    Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
    Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of the serum levels of complement during the first year of life].
    Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
    An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IFN-alpha on total haemolytic activity of CH50 complement system and C3, C4 levels in children with chronic hepatitis C.
    Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J
    Med Sci Monit; 2001 May; 7 Suppl 1():202-6. PubMed ID: 12211720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of complement system predicts the outcome of patients with severe thermal injury.
    Kang HJ; Kim JH; Lee EH; Lee YK; Hur M; Lee KM
    J Burn Care Rehabil; 2003; 24(3):148-53. PubMed ID: 12792234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum complement levels and severity of sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement studies in BN rats with mercuric chloride-induced immune glomerulonephritis.
    Capron M; Ayed K; Druet E; Sapin C; Mandet C; Druet P; Girard JF
    Ann Immunol (Paris); 1980; 131D(1):43-55. PubMed ID: 7436354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption therapy and complement activation.
    Pták J; Lochman J
    Transfus Apher Sci; 2005 Jun; 32(3):263-7. PubMed ID: 15944112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and IgG subclasses in agammaglobulinemic patients.
    Grumach AS; Kirschfink M
    Exp Clin Immunogenet; 1995; 12(1):10-5. PubMed ID: 7710760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.